PTK2 and breast carcinoma: The results are consistent with oestrogen-responsive breast cancer cell attachment activating FAK to signal through the PI3-kinase/Akt/Bad pathway to provide an important cell survival signal in attached oestrogen-responsive breast cancer cells.